Meeting
2016 ASCO Annual Meeting
Influence of induction chemotherapy (IC) in trimodality-eligible esophageal cancer patients: Secondary analysis of a randomized trial.
Authors
Yusuke Shimodaira
The University of Texas MD Anderson Cancer Center, Houston, TX
Yusuke Shimodaira , Rebecca Slack , Hsiang-Chun Chen , Manoop S. Bhutani , Jeffrey H Lee , Brian Weston , Elena Elimova , Quan Lin , Kazuto Harada , Fatemeh G Amlashi , Dilsa Mizrak , Mariela A. Blum , Jack A. Roth , Stephen Swisher , Heath Devin Skinner , Wayne Lewis Hofstetter , Ritsuko Komaki , Garrett L. Walsh , Jaffer A. Ajani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
00525915
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4027)
DOI
10.1200/JCO.2016.34.15_suppl.4027
Abstract #
4027
Poster Bd #
19
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
16-covariate propensity score matching between trimodality (TMT)-eligible esophagogastric cancer (EC) patients who had surgery and those who declined surgery after preoperative chemoradiation.
First Author: Takashi Taketa
Poster
2012 Gastrointestinal Cancers Symposium
Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation.
First Author: Takashi Taketa
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Abemaciclib in patients (pts) with esophageal cancer (EC) with CDKN2A loss or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
First Author: Tareq Al Baghdadi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling survival strategies: The impact of treatment modalities on patients with esophageal cancer and the role of racial disparities.
First Author: Dani Ran Castillo